Press release
Investigation announced for Investors in Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) over potential Wrongdoing

An investigation on behalf of investors in Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) shares over potential wrongdoing.
Investors who purchased shares of Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Consensus Cloud Solutions, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Los Angeles, CA based Consensus Cloud Solutions, Inc., together with its subsidiaries, provides information delivery services with a software-as-a-service platform worldwide. Consensus Cloud Solutions, Inc. reported that its annual Total Revenue rose from $352.66 million in 2021 to $362.42 million in 2022, and that its Net Income declined from $109 million in 2021 to $72.41 million in 2022.
On February 22, 2023, Consensus Cloud Solutions, Inc. (NASDAQ: CCSI announced that "as a result of the unintentional errors noted [below], the audit committee (the 'Audit Committee') of the board of directors of the Company reached a determination to restate its unaudited financial statements for the three and nine month periods ended September 30, 2022." The "unintentional errors" were "primarily relating to (i) to a legacy accounting practice, inherited from the spin transaction in its SoHo business that grossed up revenue by $1.9 million and $5.3 million for the three and nine month periods ended September 30, 2022, respectively, with a corresponding offset to bad debt expense ('SoHo Error') and (ii) the timing of revenue recognition of $2.2 million and $2.5 million for the three and nine month periods ended September 30, 2022, respectively, which after review, the Company has concluded should be reclassified as deferred revenue ('Deferred Revenue Error')."
Shares of Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) declined from $62.08 per share on February 16, 2023, to $41.89 million on February 24, 2023.
Those who purchased shares of Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
                     Copy
                  
                 Please set a link in the press area of your homepage to this press release on openPR.  openPR disclaims liability for any content contained in this release. 
    You can edit or delete your press release Investigation announced for Investors in Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) over potential Wrongdoing here
News-ID: 3056357 • Views: …
More Releases from Shareholders Foundation
 
                                            
                                                    Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE:  …                                                
                                            
                                        
                                            An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…  
                                        
                                     
                                            
                                                    Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …                                                
                                            
                                        
                                            An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. 
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…  
                                        
                                     
                                            
                                                    Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …                                                
                                            
                                        
                                            An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…  
                                        
                                     
                                            
                                                    Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025                                                
                                            
                                        
                                            A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. 
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…  
                                        
                                    More Releases for Consensus
                                                    Release of the Consensus of the China Automotive CTO Closed-Door Summit 2025                                                
                                            
                                        
                                            On October 24, Zhao Fuquan, as the Vice President of China SAE, Director of Tsinghua Automotive Strategy Research Institute (TASRI), Lifetime Honorary President of FISITA, released the Consensus of the China Automotive CTO Closed-Door Summit 2025 at the New Energy Vehicles Plenary Session of SAECCE 2025.
Image: https://www.globalnewslines.com/uploads/2025/10/0649fc7b1e9c6b6a23c43a4e01698e89.jpg
The full text of the consensus is as follows:
In October 2025, Chief Technology Officers (CTO) from leading domestic and international automotive enterprises gathered in…  
                                        
                                    
                                                    Pinnacle of Glory, Global Consensus Ignited: SMiC Mount Fuji Partner Program Str …                                                
                                            
                                        
                                            This is an exhilarating moment! SMiC is declaring with unstoppable momentum that the new era of global DAO has officially begun! As a benchmark for global DAO, our mission is to lead global partners to the pinnacle of wealth, and our vision is to surpass Bitcoin in consensus of digital credentials! Now, the SMiC Mount Fuji Partner Program is about to launch, and this unprecedented event will ignite the passion…  
                                        
                                    
                                                    BlockDAG: Revolutionizing Digital Consensus with Eco-Conscious Efficiency                                                
                                            
                                        
                                            Image: https://www.abnewswire.com/uploads/7c36a582da6df7df428a05159a99dadc.jpg
In an era where digital transformation and environmental sustainability are paramount, BlockDAG emerges as a groundbreaking proof-of-work consensus mechanism that promises to redefine the cryptosphere. Leveraging a Directed Acyclic Graph (DAG) structure, BlockDAG is designed to deliver unparalleled speed, security, and efficiency, setting a new standard for digital transactions.
Innovative Architecture
BlockDAG's architecture distinguishes itself from traditional blockchain technologies through its innovative Directed Acyclic Graph structure. This design prioritizes eco-conscious practices…  
                                        
                                    
                                                    Analysts Consensus Reaffirms Significant Upside Potential for Cardiol Therapeuti …                                                
                                            
                                        
                                            According to Gantoss, Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) has many things going in its favor right now heading into a critical Phase 2 trial readout in RP in June that he believes will lead to a positive outcome.
Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, has been attracting substantial interest from investors…  
                                        
                                    
                                                    SecuX to Host Blockchain Security Event at Consensus 2024                                                
                                            
                                        
                                            You're Invited: Safeguarding the Future - Innovations in Blockchain Security
May 23, 2024 Austin, Texas, SecuX, a blockchain security and cryptocurrency hardware wallet company, join us on May 29, 2024, at 3:00 PM at Halcyon, Austin, Texas, for an exclusive side event at the 2024 Consensus conference. "Safeguarding the Future: Innovations in Blockchain Security" brings together industry leaders and experts to explore the latest trends and innovations in blockchain security.
Engage with…  
                                        
                                    
                                                    Tacans Labs Set To Launch Two Revolutionary DEXes During Consensus 2023                                                
                                            
                                        
                                            Tacans Labs, the DeFi venture builder arm of Tacans, is proud to announce the upcoming launch of two of its key decentralized trading platforms during Consensus 2023, which is set to be held in Austin, Texas, between the 26th and 28th of April.
Building Scalable Infrastructure That Will Enhance The DeFi Experience
Tacans was founded in 2021 and has assembled a team of industry veterans to lead the development of its platforms.…